- Home
- BIDU vs IQV Comparison
BIDU vs IQV Comparison
Compare BIDU & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIDU
- IQV
- Stock Information
- Founded
- BIDU 2000
- IQV 1982
- Country
- BIDU China
- IQV United States
- Employees
- BIDU N/A
- IQV N/A
- Industry
- BIDU Computer Software: Programming Data Processing
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BIDU Technology
- IQV Health Care
- Exchange
- BIDU Nasdaq
- IQV Nasdaq
- Market Cap
- BIDU 28.5B
- IQV 24.9B
- IPO Year
- BIDU 2005
- IQV 2013
- Fundamental
- Price
- BIDU $86.86
- IQV $148.92
- Analyst Decision
- BIDU Buy
- IQV Buy
- Analyst Count
- BIDU 11
- IQV 20
- Target Price
- BIDU $116.09
- IQV $230.55
- AVG Volume (30 Days)
- BIDU 2.8M
- IQV 2.0M
- Earning Date
- BIDU 05-21-2025
- IQV 05-06-2025
- Dividend Yield
- BIDU N/A
- IQV N/A
- EPS Growth
- BIDU 19.61
- IQV 0.26
- EPS
- BIDU 9.04
- IQV 7.35
- Revenue
- BIDU $18,238,549,935.00
- IQV $15,497,000,000.00
- Revenue This Year
- BIDU $5.00
- IQV $4.08
- Revenue Next Year
- BIDU $5.88
- IQV $5.88
- P/E Ratio
- BIDU $9.61
- IQV $20.37
- Revenue Growth
- BIDU N/A
- IQV 2.84
- 52 Week Low
- BIDU $74.71
- IQV $135.97
- 52 Week High
- BIDU $116.25
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- BIDU 47.32
- IQV 42.96
- Support Level
- BIDU $85.88
- IQV $143.65
- Resistance Level
- BIDU $92.22
- IQV $156.50
- Average True Range (ATR)
- BIDU 1.94
- IQV 5.66
- MACD
- BIDU 0.17
- IQV 1.46
- Stochastic Oscillator
- BIDU 36.27
- IQV 59.49
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.